Article

Distinct pulmonary and systemic effects of dexamethasone in severe COVID-19

Research square · 2023 · Lucile P. A. Neyton, author Ravi K. Patel, author Aartik Sarma, author Andrew Willmore, author Sidney C. Haller, author Kirsten N. Kangelaris, author Walter L. Eckalbar, author David J. Erle, author Matthew F. Krummel, author Carolyn M. Hendrickson, author Prescott G. Woodruff, author Charles R. Langelier, author Carolyn S. Calfee, author Gabriela K. Fragiadakis, author

Key facts

Title Distinct pulmonary and systemic effects of dexamethasone in severe COVID-19
First author Lucile P. A. Neyton, author Ravi K. Patel, author Aartik Sarma, author Andrew Willmore, author Sidney C. Haller, author Kirsten N. Kangelaris, author Walter L. Eckalbar, author David J. Erle, author Matthew F. Krummel, author Carolyn M. Hendrickson, author Prescott G. Woodruff, author Charles R. Langelier, author Carolyn S. Calfee, author Gabriela K. Fragiadakis, author
Journal Research square
Published Aug 6, 2023
DOI 10.21203/rs.3.rs-3168149/v1
Devices mentioned 020586, K121894
Product codes mentioned NSU, PCH

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature